Maziarz, Richard T. http://orcid.org/0000-0002-8184-7099
Levis, Mark http://orcid.org/0000-0003-0473-6982
Patnaik, Mrinal M. http://orcid.org/0000-0001-6998-662X
Scott, Bart L.
Mohan, Sanjay R.
Deol, Abhinav http://orcid.org/0000-0003-0947-8871
Rowley, Scott D.
Kim, Dennis D. H.
Hernandez, Daniela
Rajkhowa, Trivikram
Haines, Kelly
Bonifacio, Gaetano
Rine, Patrice
Purkayastha, Das
Fernandez, Hugo F.
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
Received: 14 April 2020
Revised: 26 October 2020
Accepted: 11 November 2020
First Online: 7 December 2020
Compliance with ethical standards
:
: RTM discloses honoraria from Novartis, Incyte, Juno Therapeutics, and Kite Therapeutics; Board of Directors membership at Novartis Pharmaceuticals Corporation; consultancies with Incyte and Juno Therapeutics; and patents and royalties from Athersys, Inc; as an OHSU employee who provided and received payment for consultancy services to Novartis Pharmaceuticals Corporation, this potential conflict of interest has been reviewed and managed by OHSU. ML discloses consultancy with Novartis Pharmaceuticals Corporation, Astellas, and Daiichi Sankyo; research funding from Novartis Pharmaceuticals Corporation, Astellas, and Fujifilm; and honoraria from Novartis Pharmaceuticals Corporation. MMP discloses advisory board membership with Stemline. BLS discloses consultancy with Acceleron, Incyte, Agios, Celgene, and Alexion and research funding from Novartis Pharmaceuticals Corporation and Celgene. SRM has nothing to disclose. AD discloses consultancies with Kite Therapeutics and Novartis Pharmaceuticals Corporation. SDR has nothing to disclose. DDHK discloses consultancies with Novartis Pharmaceuticals Corporation, Bristol-Meyers Squibb, Paladin, and Pfizer and honoraria and research funding from Novartis Pharmaceuticals Corporation and Bristol-Meyers Squibb. DH and TR have nothing to disclose. KH discloses former employment with Novartis Pharmaceuticals Corporation and current employment with Regeneron Pharmaceuticals, Inc. GB and DP disclose employment with Novartis Pharmaceuticals Corporation. PR discloses former employment with Novartis Pharmaceuticals Corporation and current employment with Target CW. HFF discloses honoraria from Pfizer and Sanofi and speakers’ bureau membership with Sanofi.